Bullish
This Healthcare Stock Is Soaring
CVS is firing on all cylinders.
Recent News
Powered by Alpha Vantage
Bullish
CVS Health Corporation ( CVS ) is Attracting Investor Attention: Here is What You Should Know
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Bullish
CVS Health Makes Headway in Stabilizing Aetna: What's Driving It?
CVS makes progress in stabilizing Aetna with leadership, risk management and operational changes.
Neutral
CVS Health Corporation ( CVS ) technical analysis - CVS Health ( NYSE:CVS )
Shares of CVS Health Corporation ( CVS ) find support around the $70 level. This level was previously a resistance level. Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On CVS Health Corporation CVS is trading higher on Tuesday. This follows yesterday's sell-off of ...
Bullish
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Bullish
Wall Street Analysts See CVS Health ( CVS ) as a Buy: Should You Invest?
The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
AI Tools
Key Metrics
Trend: Uptrend
As of 2025-09-09 (Snapshot)
CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.
52W High
$74.53
52W Low
$42.12
MA Status:
50D: Above
200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.62
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
20.55
Forward P/E (<15 better)
10.21
EV/EBITDA (<8 favorable)
11.43
EV/Revenue (<3 favorable)
0.42
P/S (TTM) (<3 favorable)
0.24
P/B (<3 favorable)
1.21
Ownership
Institution‑heavySource: Overview
Insiders (1–5% typical)
1.07%
Institutions (25–75% balanced)
88.11%
Shares Outstanding
1,268,330,000
Float
1,265,676,000
Dividend Yield (2–6% sweet spot)
0.04%
Ex‑Dividend Date
2025-07-22
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
384,328,991,000
Gross Profit (TTM)
51,134,001,000
EPS (TTM)
3.59
Profit Margin (>10% good)
0.01%
Operating Margin (TTM) (higher better)
0.03%
ROE (TTM) (>15% strong)
0.06%
EPS YoY (Quarterly) (>10% good)
-0.43
Revenue YoY (Quarterly) (>8% good)
0.08
Momentum
Bearish momentumValue
2.3893
Previous
2.3263
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025